These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 30573162)
1. Higher average potency across the United States is associated with progression to first cannabis use disorder symptom. Arterberry BJ; Treloar Padovano H; Foster KT; Zucker RA; Hicks BM Drug Alcohol Depend; 2019 Feb; 195():186-192. PubMed ID: 30573162 [TBL] [Abstract][Full Text] [Related]
2. Cannabis use disorder among people using cannabis daily/almost daily in the United States, 2002-2016. Santaella-Tenorio J; Levy NS; Segura LE; Mauro PM; Martins SS Drug Alcohol Depend; 2019 Dec; 205():107621. PubMed ID: 31698323 [TBL] [Abstract][Full Text] [Related]
3. Cannabis use disorders among adults in the United States during a time of increasing use of cannabis. Compton WM; Han B; Jones CM; Blanco C Drug Alcohol Depend; 2019 Nov; 204():107468. PubMed ID: 31586809 [TBL] [Abstract][Full Text] [Related]
4. Factors associated with the timing and onset of cannabis use and cannabis use disorder: results from the 2007 Australian National Survey of Mental Health and Well-Being. Butterworth P; Slade T; Degenhardt L Drug Alcohol Rev; 2014 Sep; 33(5):555-64. PubMed ID: 25186194 [TBL] [Abstract][Full Text] [Related]
5. Examining Associations Between Cannabis Use Disorder and Measures of Weekly and Within-Day Cannabis Frequency, Quantity, and Potency in College Students. Piercey CJ; Mataczynski M; Stallsmith VT; Emery NN; Karoly HC Cannabis Cannabinoid Res; 2024 Jun; 9(3):e917-e923. PubMed ID: 37699241 [No Abstract] [Full Text] [Related]
6. Developing a phone-based measure of impairment after acute oral ∆ Pabon E; de Wit H J Psychopharmacol; 2019 Sep; 33(9):1160-1169. PubMed ID: 31407943 [TBL] [Abstract][Full Text] [Related]
7. Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study. van der Pol P; Liebregts N; Brunt T; van Amsterdam J; de Graaf R; Korf DJ; van den Brink W; van Laar M Addiction; 2014 Jul; 109(7):1101-9. PubMed ID: 24628797 [TBL] [Abstract][Full Text] [Related]
8. Made from concentrate? A national web survey assessing dab use in the United States. Sagar KA; Lambros AM; Dahlgren MK; Smith RT; Gruber SA Drug Alcohol Depend; 2018 Sep; 190():133-142. PubMed ID: 30029166 [TBL] [Abstract][Full Text] [Related]
9. Influence of tiagabine maintenance on cannabis effects and related behaviors in daily cannabis users. Wesley MJ; Westgate PM; Stoops WW; Kelly TH; Hays LR; Lile JA Exp Clin Psychopharmacol; 2018 Jun; 26(3):310-319. PubMed ID: 29863387 [TBL] [Abstract][Full Text] [Related]
10. Longitudinal modeling of transmissible risk in boys who subsequently develop cannabis use disorder. Kirisci L; Tarter RE; Ridenour T; Reynolds M; Vanyukov M Am J Drug Alcohol Abuse; 2013 May; 39(3):180-5. PubMed ID: 23721533 [TBL] [Abstract][Full Text] [Related]
11. Prevalence and correlates of treatment utilization among adults with cannabis use disorder in the United States. Wu LT; Zhu H; Mannelli P; Swartz MS Drug Alcohol Depend; 2017 Aug; 177():153-162. PubMed ID: 28599214 [TBL] [Abstract][Full Text] [Related]
12. Association of High-Potency Cannabis Use With Mental Health and Substance Use in Adolescence. Hines LA; Freeman TP; Gage SH; Zammit S; Hickman M; Cannon M; Munafo M; MacLeod J; Heron J JAMA Psychiatry; 2020 Oct; 77(10):1044-1051. PubMed ID: 32459328 [TBL] [Abstract][Full Text] [Related]
13. Validation of self-reported cannabis dose and potency: an ecological study. van der Pol P; Liebregts N; de Graaf R; Korf DJ; van den Brink W; van Laar M Addiction; 2013 Oct; 108(10):1801-8. PubMed ID: 23627816 [TBL] [Abstract][Full Text] [Related]
14. The association of specific traumatic experiences with cannabis initiation and transition to problem use: Differences between African-American and European-American women. Werner KB; McCutcheon VV; Agrawal A; Sartor CE; Nelson EC; Heath AC; Bucholz KK Drug Alcohol Depend; 2016 May; 162():162-9. PubMed ID: 27012434 [TBL] [Abstract][Full Text] [Related]
15. The association between lifetime cannabis use and dysthymia across six birth decades. Livne O; Razon L; Rehm J; Hasin DS; Lev-Ran S J Affect Disord; 2018 Jul; 234():327-334. PubMed ID: 29605793 [TBL] [Abstract][Full Text] [Related]
16. The relevance of age at first alcohol and nicotine use for initiation of cannabis use and progression to cannabis use disorders. Behrendt S; Beesdo-Baum K; Höfler M; Perkonigg A; Bühringer G; Lieb R; Wittchen HU Drug Alcohol Depend; 2012 Jun; 123(1-3):48-56. PubMed ID: 22071122 [TBL] [Abstract][Full Text] [Related]
17. Predictive validity of cannabis consumption measures: Results from a national longitudinal study. Buu A; Hu YH; Pampati S; Arterberry BJ; Lin HC Addict Behav; 2017 Oct; 73():36-40. PubMed ID: 28463803 [TBL] [Abstract][Full Text] [Related]
18. Trends in cannabis use disorders among racial/ethnic population groups in the United States. Wu LT; Zhu H; Swartz MS Drug Alcohol Depend; 2016 Aug; 165():181-90. PubMed ID: 27317045 [TBL] [Abstract][Full Text] [Related]
19. Predicting the transition from frequent cannabis use to cannabis dependence: a three-year prospective study. van der Pol P; Liebregts N; de Graaf R; Korf DJ; van den Brink W; van Laar M Drug Alcohol Depend; 2013 Dec; 133(2):352-9. PubMed ID: 23886472 [TBL] [Abstract][Full Text] [Related]
20. State medical marijuana laws, cannabis use and cannabis use disorder among adults with elevated psychological distress. McBain RK; Wong EC; Breslau J; Shearer AL; Cefalu MS; Roth E; Burnam MA; Collins RL Drug Alcohol Depend; 2020 Oct; 215():108191. PubMed ID: 32736294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]